Jing Jiang
Director/Board Member at Wuxi Shenrui Bio-Pharmaceuticals Co., Ltd.
Network origin in Jing Jiang first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
Wuxi Shenrui Bio-Pharmaceuticals Co., Ltd.
 Wuxi Shenrui Bio-Pharmaceuticals Co., Ltd. Medical SpecialtiesHealth Technology Wuxi Shenrui Bio-Pharmaceuticals Co., Ltd. is a private company that manufactures medical equipment. The company is based in Wuxi, China. The Chinese company was founded in 1999. The CEO is Qing Song Sheng.
5
| Private Company | Medical Specialties | 5 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Jing Jiang via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| GEMPHARMATECH CO., LTD. | Biotechnology | Director/Board Member | |
| Yale University | College/University | Doctorate Degree | |
| JIANGSU HUALAN NEW PHARMACEUTICAL MATERIAL CO.,LTD. | Containers/Packaging | Director/Board Member | |
Genfleet Therapeutics (Shanghai), Inc.
 Genfleet Therapeutics (Shanghai), Inc. Miscellaneous Commercial ServicesCommercial Services Genfleet Therapeutics (Shanghai), Inc. is a Chinese clinical-stage biotechnology company that focuses on developing novel drug candidates for unmet medical needs in oncology and immunology. The company is based in Shanghai, China, and was founded in 2017 by Jiong Lan and Qiang Lü. The company has built up industry-leading capabilities and expertise in developing both small molecules and biologics since its inception in 2017. Genfleet's proprietary and fully integrated R&D platform highlights multiple cutting-edge products with novel mechanisms and IP. The company's pipeline includes over 10 programs, many of which have entered multi-regional clinical trials across China. Genfleet has completed co-development partnerships with a number of publicly listed companies worldwide. Jiong Lan has been the CEO since 2017. | Miscellaneous Commercial Services | Director/Board Member | |
Innolake Pharmaceuticals (Hangzhou) Co., Ltd.
 Innolake Pharmaceuticals (Hangzhou) Co., Ltd. Pharmaceuticals: MajorHealth Technology Innolake Pharmaceuticals (Hangzhou) Co., Ltd. is a company based in Hangzhou, China that engages in the development and commercialization of therapeutic drugs for tumors and immune system diseases. The Chinese company was founded in 2020 by Ru Lei Chen and Ming De Xia, with Ming De Xia serving as the CEO since 2020. | Pharmaceuticals: Major | Director/Board Member |
Statistics
International
| China | 5 |
| United States | 2 |
Sectoral
| Health Technology | 3 |
| Consumer Services | 2 |
| Process Industries | 2 |
| Commercial Services | 2 |
Operational
| Director/Board Member | 8 |
| Chief Executive Officer | 1 |
| Chairman | 1 |
| Doctorate Degree | 1 |
| Independent Dir/Board Member | 1 |
Most connected contacts
| Insiders | |
|---|---|
| Dan Liu | 6 |
| Qing Song Sheng | 1 |
| Qing Zhong Tan | 1 |
| Zeng Jiao Sui | 1 |
| Yun Feng | 1 |
- Stock Market
- Insiders
- Jing Jiang
- Company connections
